Macrophage activation syndrome as the extreme form of Kawasaki disease

Korean Journal of Pediatric Infectious Diseases

Volumn 17, Issue 2, 2010, Pages 177-181

  Park, Hyoun Jin ^a   Cho, Yoon Jeong ^a   Bae, E Young ^a   Choi, Ui Yoon ^a   Lee, Soo Young ^a   Jeong, Dae Chul ^a   Lee, Kyung Yil ^a   Kang, Jin Han ^a  

^a The Catholic University of Korea   (South Korea)

Author keywords

Hemophagocytic lymphohistiocytosis; Kawasaki disease; Macrophage activation syndrome

Indexed keywords

IMMUNOGLOBULIN; STEROID;

ARTICLE; CASE REPORT; CHILD; CLINICAL FEATURE; DRUG TREATMENT FAILURE; ERYTHROPHAGOCYTOSIS; FEMALE; FEVER; HEPATOSPLENOMEGALY; HUMAN; MACROPHAGE ACTIVATION SYNDROME; MUCOCUTANEOUS LYMPH NODE SYNDROME; PRESCHOOL CHILD; SYMPTOM;

EID: 84869164855     PISSN: 12263923     EISSN: None     Source Type: Journal    
DOI: 10.14776/kjpid.2010.17.2.177     Document Type: Article

References (20)

1. Newburger JW, Takahashi M, Gerber MA, Gewitz MH, Tani LY, Burns JC, et al. Diagnosis, treatment, and longterm management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004;114:1708-33.
2. Rowley AH, Shulman ST. Kawasaki Disease. In : Kliegman RM, Behrman RE, Jenson HB, Stanton BF, Editors. Textbook of pediatrics. 18th ed. Philadelphia : WB Saunders Co, 2007:1036-42.
3. Hadchouel M, Prieur AM, Griscelli C. Acute hemorrhagic, hepatic, and neurologic manifestations in juvenile rheumatoid arthritis: Possible relationship to drugs or infection. J Pediatr 1985;41:561-6.
4. Ravelli A. Macrophage activation syndrome. Curr Opin Rheumatol 2002;14:548-52.
5. Grom AA. Macrophage activation syndrome and reactive hemophagocytic lymphohistiocytosis: the same entities? Curr Opin Rheumatol 2003;15:587-90.
6. Castillo L, Carcillo J. Secondary hemophagocytic lymphohistiocytosis and severe sepsis/systemic inflammatory response syndrome/multiorgan dysfunction syndrome/macrophage activation syndrome share common intermediate phenotypes on a spectrum of inflammation. Pediatr Crit Care Med 2009;10:387-92.
7. Ohga S, Ooshima A, Fukushige J, Ueda K. Histiocytic haemophagocytosis in a patient with Kawasaki disease: changes in the hypercytokinaemic state. Eur J Pediatr 1995;154:539-41.
8. Muise A, Tallett SE, Silverman ED. Are children with Kawasaki disease and prolonged fever at risk for macrophage activation syndrome? Pediatrics 2003;112:e495-7.
9. Palazzi DL, McClain KL, Kaplan SL. Hemophagocytic syndrome after Kawasaki disease. Pediatr Infect Dis J 2003;22:663-6.
10. Latino GA, Manlhiot C, Yeung RS, Chahal N, McCrindle BW. Macrophage Activation Syndrome in the Acute Phase of Kawasaki Disease. J Pediatr Hematol Oncol 2010 in press.
11. Kelly A, Ramanan AV. Recognition and management of macrophage activation syndrome in juvenile arthritis. Curr Opin Rheumatol 2007;19:477-81.
12. Palazzi DL, McClain KL, Kaplan SL. Hemophagocytic syndrome in children: an important diagnostic consideration in fever of unknown origin. Clin Infect Dis 2003; 36:306-12.
13. Szyper-Kravitz M. The Hemophagocytic syndrome/Macrophage Activation Syndrome: A Final Common Pathway of a Cytokine Storm. Isr Med Assoc J 2009;11: 633-4.
14. Behrens EM. Macrophage activation syndrome in rheumatic disease: what is the role of the antigen presenting cell? Autoimmun Rev 2008;7:305-8.
15. Kim JD, Na DJ, Kang JH, Lee KS, Sung KY. A case of systemic-onset juvenile rheumatoid arthritis with multiple complications. J Korean Pediatr Soc 1988;31:948-52.
16. Hwang JY, No SM, Lee J, Jang PS, Kim YH, Kim JT, et al. A case of hemophagocytic lymphohistiocytosis in a child with systemic lupus erythematosus. J Korean Pediatr Soc 2003;46:1029-31.
17. Hur M, Kim YC, Lee KM, Kim KN. Macrophage activation syndrome in a child with systemic juvenile rheumatoid arthritis. J Korean Med Sci 2005;20:695-8.
18. Lee SY, Yoo HJ, Kwak GY, Jeong DC, Kang JH. Macrophage activation syndrome as the presenting manifestation of juvenile rheumatoid arthritis. Pediatr Clin Immunol 2008;2:30-4.
19. Lee SY, Han SB, Jeong DC, Lee KY, Kang JH. Among the patients with hemophagocytic lymphohistiocytosis, who need 42-week chemotheray including etoposide? Program and abstract, the 58th Annual Fall Meeting of the Korean Pediatric Society; 2009 Oct 23-24; Seoul. Seoul : The Korean Pediatric Society, 2009:220.
20. Henter JI, Horne A, Arico M, Egeler RM, Filipovich AH, Imashuku S, et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007;48:124-31.